Aberrant methylation of microRNA-34b/c is a predictive marker of metachronous gastric cancer risk.
about
Gastric cancer: The times they are a-changin'Recent advances in the molecular diagnostics of gastric cancerAn updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versaPFK15, a Small Molecule Inhibitor of PFKFB3, Induces Cell Cycle Arrest, Apoptosis and Inhibits Invasion in Gastric CancerOverexpression of stromal interaction molecule 1 may promote epithelial‑mesenchymal transition and indicate poor prognosis in gastric cancerEpigenetic alteration and microRNA dysregulation in cancerMicroRNAs: new players in IBD.Promoter methylated microRNAs: potential therapeutic targets in gastric cancer.The genetic association between pri-miR-34b/c polymorphism (rs4938723 T > C) and susceptibility to cancers: evidence from published studies.Relationship Between Noncoding RNA Dysregulation and Epigenetic Mechanisms in Cancer.Gastric Carcinogenesis and Underlying Molecular Mechanisms: Helicobacter pylori and Novel Targeted Therapy.MicroRNA mediated regulation of immunity against gram-negative bacteria.Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection.Morphologic characterization of residual DNA methylation in the gastric mucosa after Helicobacter pylori eradication.Diagnosis value of aberrantly expressed microRNA profiles in lung squamous cell carcinoma: a study based on the Cancer Genome Atlas.Helicobacter pylori Is Associated with miR-133a Expression through Promoter Methylation in Gastric Carcinogenesis.Long-term effects of H. pylori eradication on epigenetic alterations related to gastric carcinogenesis
P2860
Q26776195-6526D11A-F448-497A-8604-57CFB8EAF05DQ26785548-8FA7E09D-AFF6-4E5D-B1EF-0F3C1DC5774FQ27027592-05B8AC99-2746-4CCC-823D-91AFC9666723Q28554349-FB4CEFC9-2954-48DD-B035-864C0DEB4332Q33828126-E55EA0DC-8018-4B1B-96C5-DD7773B35871Q34392645-2AB78F64-9FAC-40B6-B1E6-59F5952A366CQ35135542-616F3DE2-8E15-4775-972F-905CBFA9934DQ38263343-4329A96B-D183-41D5-A4B1-EBEED88D66EDQ38395205-D39BBC39-20EC-496E-A80A-02EA5C1C1CC1Q38885469-D04DF2E3-D5B6-4DF5-9E48-C99B4D619BE5Q39838743-6B294241-34D4-4BB6-A68B-968B9FD1EAFCQ40097133-14765C67-41E9-4E4C-B5E4-DD8801D3DD51Q40097546-25F0C9C8-B705-457C-8FBA-FFC744839C3BQ40975827-5369E93F-592A-44AA-B51F-BD54607FAE96Q47113981-B40CE7D5-E0D0-4525-9A65-826A19414E3AQ49218186-67352EFD-FF63-4843-8629-2B4638FD4834Q58698615-87694B85-26B5-4EE4-BD2B-0992BF362E52
P2860
Aberrant methylation of microRNA-34b/c is a predictive marker of metachronous gastric cancer risk.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Aberrant methylation of microR ...... achronous gastric cancer risk.
@ast
Aberrant methylation of microR ...... achronous gastric cancer risk.
@en
type
label
Aberrant methylation of microR ...... achronous gastric cancer risk.
@ast
Aberrant methylation of microR ...... achronous gastric cancer risk.
@en
prefLabel
Aberrant methylation of microR ...... achronous gastric cancer risk.
@ast
Aberrant methylation of microR ...... achronous gastric cancer risk.
@en
P2093
P2860
P1476
Aberrant methylation of microR ...... tachronous gastric cancer risk
@en
P2093
Akiko Sato
Eiichiro Yamamoto
Hiro-O Yamano
Hiromu Suzuki
Hiroyuki Yamamoto
Katsuhiko Nosho
Kenjiro Yoshikawa
Kohzoh Imai
Masahiro Kai
Masami Ashida
P2860
P304
P356
10.1007/S00535-013-0861-7
P577
2013-08-13T00:00:00Z